| 2D Structure | |
| CID | 5379 |
| IUPAC Name | 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid |
| InChI | InChI=1S/C19H22FN3O4/c1-10-8-22(6-5-21-10)16-14(20)7-12-15(18(16)27-2)23(11-3-4-11)9-13(17(12)24)19(25)26/h7,9-11,21H,3-6,8H2,1-2H3,(H,25,26) |
| InChI Key | XUBOMFCQGDBHNK-UHFFFAOYSA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C19H22FN3O4 |
| Molecular Weight | 375.4 |
| synonyms | ['Gatifloxacin', '112811-59-3', 'Tequin', 'Gatiflo', 'Zymar', 'AM-1155', 'Gatifloxacine', 'Zymaxid', 'Zymer', 'gatifloxacin anhydrous', 'AM 1155', '3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-', 'gatifloxacino', '1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid', 'gatifloxacinum', 'DTXSID5045704', 'PD-135432', 'NSC-758701', 'CHEBI:5280', 'BMS-206584-01', '1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid', '81485Y3A9A', 'Gatifloxacin (sesquihydrate)', '(+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid', 'DTXCID3025704', '1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid', 'BMS-20658401', 'BMS206584', 'BMS 206584', 'RefChem:142731', 'J01MA16', 'S01AE06', '1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-4-ium-1-yl)-4-oxoquinoline-3-carboxylate', 'L4618BD7KJ', '1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid', '1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid', 'CG 5501', 'BMS-206584', 'GTFX', 'MFCD00895399', '160738-57-8', 'Gatifloxacin (INN)', 'CHEMBL31', 'gatifloxin', 'Gatilox', 'Gatiquin', 'Gatispan', 'Gaity', '1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid', 'NCGC00068236-02', 'Tymer', 'Gatifloxacin 100 microg/mL in Acetonitrile', 'GATIFLOXACIN [INN]', 'Gatifloxacin [USAN:INN]', 'Bonoq', 'BMS 206584-01', 'PD 135432', '(+/-)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid', '1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid', '1-Cyclopropyl-6-fluoro-8-methoxy-1,4-dihydro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylicacid', 'SMR000043336', 'CAS-112811-59-3', 'Zymer (TN)', 'SR-01000610458', 'CG-5501', 'Gatifloxcin', 'Tequin in dextrose 5% in plastic container', 'AM-1155 (*Sesquihydrate*)', 'Gatifloxacin & Gamma Interferon', 'UNII-81485Y3A9A', 'Kinome_3137', 'Spectrum_001909', 'CPD000043336', 'Gatifloxacin (Standard)', 'Spectrum2_000487', 'Spectrum3_000999', 'Spectrum4_001127', 'Spectrum5_001468', 'GATIFLOXACIN [MI]', 'Epitope ID:540297', 'SCHEMBL22591', 'BSPBio_002697', 'KBioGR_001613', 'KBioSS_002448', 'MLS000040259', 'MLS000759493', 'MLS006011836', 'GATIFLOXACIN [WHO-DD]', 'SPECTRUM1504272', 'SPBio_000353', 'orb1309089', 'orb3025506', 'SCHEMBL29356306', 'Gatifloxacin - Bio-X trade mark', 'GTPL10816', 'KBio2_002442', 'KBio2_005010', 'KBio2_007578', 'KBio3_001917', 'MSK5720', 'GLXC-22553', 'HMS1922J15', 'HMS2090K10', 'HMS2093G06', 'HMS2233D20', 'HMS3259P06', 'HMS3372J10', 'HMS3372J12', 'HMS3715N03', 'HMS5079D13', 'Pharmakon1600-01504272', 'ALBB-028535', 'RKL10068', 'Tox21_110984', 'AM1155', 'BBL010485', 'BDBM50117914', 'CCG-39529', 'CG5501', 'EBC-11236', 'HB3263', 'HY-10581R', 'MSK5720-100M', 'NSC758701', 's1340', 'STK801620', 'AKOS004119932', 'AKOS016340697', 'Tox21_110984_1', 'AC-1944', 'AC23649', 'CS-1841', 'DB01044', 'KS-1066', 'NC00702', 'NSC 758701', 'NCGC00068236-03', 'NCGC00068236-04', 'NCGC00068236-05', 'NCGC00068236-06', 'NCGC00068236-07', 'NCGC00068236-08', 'NCGC00095126-01', 'NCGC00095126-02', 'NCGC00178525-01', 'BG300001', 'HY-10581', 'SY070194', 'SBI-0206764.P001', 'DB-019145', 'G0325', 'Gatifloxacin Solution in Methanol, 100ug/mL', 'NS00004983', 'C07661', 'D08011', 'AB00171654-13', 'AB00171654-14', 'AB00171654_16', 'AB00171654_17', 'EN300-19768783', 'Q2365016', 'SR-01000610458-2', 'SR-01000610458-3', 'BRD-A74980173-001-02-8', 'BRD-A74980173-001-06-9', 'BRD-A74980173-001-11-9', 'BRD-A74980173-213-01-1', 'Z1824566854', '( inverted exclamation markA)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid sesquihydrate', '1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-3-quinolinecarboxylic acid', '1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid', '1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylicacid', '1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazino)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid', '1-cyclopropyl-7-(3-methyl-1-piperazinyl)-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid'] |
From Pubchem